The basic hematological parameters like haemoglobin can be used as a prospective screening test to assess the severity and progression of HIV infection when CD4 count is not available, especially in developing countries like Nepal where financial resources are slightly limited. This evidence concerns the gene CD4 and HIV infectious disease.